benzoxazoles has been researched along with Absence Seizure in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, XM; Ni, LY; Song, Y; Tang, JY; Zhu, MJ | 1 |
| Elahdadi Salmani, M; Goudarzi, E; Goudarzi, I; Lashkarbolouki, T | 1 |
| Socała, K; Szuster-Ciesielska, A; Wlaź, P | 1 |
| Cheng, BB; Deng, XQ; Luo, YG; Rao, BQ; Song, MX; Wu, Y; Zeng, H | 1 |
| Asadi, S; Fereidoni, M; Kordi Jaz, E; Moghimi, A; Roohbakhsh, A; Shamsizadeh, A | 1 |
| Chai, KY; Guan, LP; Jia, JH; Quan, ZS; Wei, CX | 1 |
| Avery, BA; Kaushal, N; Matsumoto, RR; McCurdy, CR; Narayanan, S; Robson, MJ; Vinnakota, H | 1 |
| Kleinrok, Z; Kolasa, K | 1 |
| Domagalina, E; Marzec, Z; Zawisza, P | 1 |
| Cacciaguerra, S; Isa, M; Kanyonyo, M; Poupaert, JH; Spampinato, S; Ucar, H; Van derpoorten, K | 1 |
| Barthwal, JP; Brumleve, SJ; Misra, RS; Parmar, SS | 1 |
11 other study(ies) available for benzoxazoles and Absence Seizure
| Article | Year |
|---|---|
Pentylenetetrazol-induced seizures are exacerbated by sleep deprivation through orexin receptor-mediated hippocampal cell proliferation.
Topics: Animals; Benzoxazoles; CA3 Region, Hippocampal; Cell Proliferation; Convulsants; Dentate Gyrus; Hippocampus; Intracellular Signaling Peptides and Proteins; Isoquinolines; Male; Naphthyridines; Neurons; Neuropeptides; Neuroprotective Agents; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Pentylenetetrazole; Pyridines; Rats; Rats, Wistar; Seizures; Sleep Deprivation; Time Factors; Urea | 2014 |
Hippocampal orexin receptors inactivation reduces PTZ induced seizures of male rats.
Topics: Animals; Benzoxazoles; Convulsants; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Isoquinolines; Male; Microinjections; Naphthyridines; Orexin Receptor Antagonists; Orexin Receptors; Pentylenetetrazole; Pyridines; Rats; Seizures; Urea | 2015 |
SB 334867, a selective orexin receptor type 1 antagonist, elevates seizure threshold in mice.
Topics: Animals; Anticonvulsants; Benzoxazoles; Brain Chemistry; Convulsants; Electroshock; Male; Mice; Muscle Strength; Myoclonus; Naphthyridines; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Pentylenetetrazole; Psychomotor Performance; Seizures; Urea | 2016 |
Design, Synthesis and Evaluation of the Antidepressant and Anticonvulsant Activities of Triazole-Containing Benzo[d]oxazoles.
Topics: Animals; Anticonvulsants; Antidepressive Agents; Benzoxazoles; Computer Simulation; Depressive Disorder; Drug Design; Drug Evaluation, Preclinical; Electroshock; GABA Modulators; gamma-Aminobutyric Acid; Male; Mice; Molecular Structure; Motor Activity; Seizures; Structure-Activity Relationship | 2017 |
SB-334867, an orexin receptor 1 antagonist, decreased seizure and anxiety in pentylenetetrazol-kindled rats.
Topics: Animals; Anxiety; Benzoxazoles; Dose-Response Relationship, Drug; Kindling, Neurologic; Male; Maze Learning; Naphthyridines; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Pentylenetetrazole; Rats; Rats, Wistar; Seizures; Urea | 2017 |
Synthesis of 2-substituted-6-(4H-1,2,4-triazol-4-yl)benzo[d]oxazoles as potential anticonvulsant agents.
Topics: Animals; Anticonvulsants; Behavior, Animal; Benzoxazoles; Carbamazepine; Disease Models, Animal; Electric Stimulation; Female; Injections, Intraperitoneal; Magnetic Resonance Spectroscopy; Male; Mice; Molecular Structure; Motor Activity; Pentylenetetrazole; Rotarod Performance Test; Seizures | 2009 |
Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodents.
Topics: Administration, Oral; Animals; Benzoxazoles; Cocaine; Cytochrome P-450 Enzyme System; Drug Interactions; Half-Life; Injections, Intraperitoneal; Ligands; Male; Mice; Motor Activity; Piperazines; Protein Binding; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT2; Receptors, sigma; Seizures | 2011 |
[Central effect of various new carbamide and succinimide derivatives of benzoxazolone-2].
Topics: Animals; Anticonvulsants; Benzoxazoles; Brain; Carbamates; Central Nervous System Depressants; Chemical Phenomena; Chemistry; Drug Evaluation, Preclinical; Female; Male; Mice; Mice, Inbred Strains; Motor Activity; Rats; Rats, Inbred Strains; Seizures; Sleep; Succinimides | 1981 |
[New carbamidobenzoxazoline-2 derivatives].
Topics: Animals; Anticonvulsants; Benzoxazoles; Chemical Phenomena; Chemistry; Drug Evaluation, Preclinical; Mice; Seizures | 1980 |
2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives: novel, potent and selective sigma1 receptor ligands.
Topics: Animals; Anticonvulsants; Benzoxazoles; Brain; Convulsants; Electroshock; Guinea Pigs; Ligands; Male; Mice; Motor Activity; Neuroprotective Agents; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Receptors, sigma; Seizures; Sigma-1 Receptor; Structure-Activity Relationship; Thiazoles | 1997 |
Substituted benzoxazole-benzthiazole-2-thiones: interrelationship between anticonvulsant activity and inhibition of nicotinamide adenine dinucleotide-dependent oxidations and monoamine oxidase.
Topics: Aminobenzoates; Animals; Anticonvulsants; Benzoxazoles; Brain; In Vitro Techniques; Isocitrates; Ketoglutaric Acids; Monoamine Oxidase Inhibitors; NAD; Oxidation-Reduction; Pentylenetetrazole; Pyruvates; Rats; Seizures; Spectrometry, Fluorescence; Succinates; Thiazoles; Thiones | 1974 |